Position in ABVX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$859,793
New position
Shares Held
6,452
first reported quarter
Ownership
0.007%
of shares outstanding
% of Portfolio
0.09%
of 13F equity value
Holder Rank
#172
of 302 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Biotechnology
Healthcare · as of Jun 30, 2026MARK ASSET MANAGEMENT LP holds $3,592,570 across 2 Biotechnology names. ABVX ranks #2 (23.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MLYS |
Mineralys Therapeutics, Inc.
|
101,289 | $2,732,777 | |
| 2 | ABVX |
Abivax S.A.
This page
|
6,452 | $859,793 |
All Filings in ABVX
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $859,793 | 6,452 | Shares | Sole | 2026-08-14 | |
| No filing history on record for this holder in this stock. | ||||||